Melissa Andrew

 Andrew Melissa

Melissa Andrew, BSc, MSc, MD

Dalhousie University

Principal Investigator

2017 Catalyst Grant Competition (Medication Optimization)-A Collaborative Intervention for Streamlining Medication Appropriateness and Deprescribing within Integrated Health-Care Teams (CAT2017-10)

Dr. Melissa K. Andrew is Associate Professor of Medicine at Dalhousie University and a consultant in Geriatric Medicine at the QEII Health Sciences Centre in Halifax. She did a Masters of Public Health at the London School of Hygiene and Tropical Medicine on a Commonwealth Scholarship and completed her PhD in Interdisciplinary Studies at Dalhousie University on the subject of frailty and social vulnerability among older adults. She is Principal Investigator of a team studying frailty and multi-morbidity in relation to dementia as part of the Canadian Consortium on Neurodegeneration in Aging. She is co-Principal Investigator of the Public Health Agency of Canada/CIHR Serious Outcomes Surveillance (SOS) Network, where she studies how frailty impacts vaccine effectiveness, burden of disease and clinical outcomes of infectious diseases in older adults. She is also engaged in other research collaborations, including studies of models of care for older adults living with frailty in Long Term Care in relation to resident Quality of Life and quality of primary care.